ARCHIVES

FDA’s Oncologic Drugs Advisory Committee recommended approval of three drugs for cancer, voted down one.

This article is from The Cancer Letter archive.

Vol. 31 No. 33 | September 16, 2005

Download PDF Visit The Full Archive

Related Articles

President Signs Supplemental Funding For NIH And FDA.

July 11, 2008

NCI Clinical Trials Enrollment Drops to 17,500

February 21, 2014

NCI Human Tissue Network Resources Available For Research

January 24, 1997

Varmus To Cut Five Percent From Cancer Centers As NCI Adjusts To “Financial disaster”

May 6, 2011

Duke Scores Highest On NCAB Review

July 14, 1978

Interim Funding: Noncompeting Renewals Reduced By 4 Percent, Competing Current Plus 7 Percent

January 8, 1982